Maples and Calder, together with Skadden, acted for Kanzhun Limited. Clifford Chance advised Morgan Stanley and Goldman Sachs. Morgan Stanley and Goldman Sachs agreed for dual...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...
You must be a Standard 1 Year member to access this content.
Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong...
You must be a Standard 1 Year member to access this content.
